IL-8 is the first chemokine described to have pro-angiogenic properties, a function that has been confirmed in a variety of tumor types, including ovarian cancer, breast cancer, lung cancer, gastric cancer, and CRC [8, 13–15]. This evidence concerns the gene CXCL8 and neoplasm.